0000880771-16-000181.txt : 20160816
0000880771-16-000181.hdr.sgml : 20160816
20160816173621
ACCESSION NUMBER: 0000880771-16-000181
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160812
FILED AS OF DATE: 20160816
DATE AS OF CHANGE: 20160816
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000880771
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943116852
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
BUSINESS PHONE: 650-358-3456
MAIL ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Xie Lan
CENTRAL INDEX KEY: 0001555794
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19825
FILM NUMBER: 161836967
MAIL ADDRESS:
STREET 1: 29F SHANGHAI TIMES SQUARE
STREET 2: NO. 93 HUAI HAI ZHONG ROAD
CITY: SHANGHAI
STATE: F4
ZIP: 200021
4
1
certent-form4.xml
PRIMARY DOCUMENT
X0306
4
2016-08-12
0000880771
SCICLONE PHARMACEUTICALS INC
SCLN
0001555794
Xie Lan
950 TOWER LANE, SUITE 900
FOSTER CITY
CA
94404
0
1
0
0
VP Finance, China CFO
Common Stock
2016-08-12
4
M
0
9333
8.83
A
9333
D
Common Stock
2016-08-12
4
S
0
9333
10.3610
D
0
D
Common Stock
2016-08-12
4
M
0
7500
4.52
A
7500
D
Common Stock
2016-08-12
4
S
0
7500
10.361
D
0
D
Common Stock
2016-08-12
4
M
0
2812
4.53
A
2812
D
Common Stock
2016-08-12
4
S
0
2812
10.3610
D
0
D
Common Stock
2016-08-12
4
M
0
12187
5.19
A
12187
D
Common Stock
2016-08-12
4
S
0
12187
10.3610
D
0
D
Common Stock
2016-08-12
4
M
0
1000
0
A
1000
D
Common Stock
2016-08-12
4
S
0
1000
10.41
D
0
D
Non-Qualified Stock Options (right to buy)
4.52
2016-08-12
4
M
0
7500
0
D
2024-03-14
Common Stock
7500
16667
D
Non-Qualified Stock Options (right to buy)
4.53
2016-08-12
4
M
0
2812
0
D
2023-04-04
Common Stock
2812
2500
D
Non-Qualified Stock Options (right to buy)
5.19
2016-08-12
4
M
0
12187
0
D
2022-08-01
Common Stock
12187
0
D
Non-Qualified Stock Options (right to buy)
8.83
2016-08-12
4
M
0
9333
0
D
2025-03-16
Common Stock
9333
18667
D
Restricted Stock Unit
2016-08-12
4
A
0
10000
0
A
Common Stock
10000
18000
D
Restricted Stock Unit
2016-08-12
4
M
0
1000
0
D
Common Stock
1000
17000
D
Granted under the Issuer's 2005 Equity Incentive Plan.
25% of such shares vest from one year from the date of grant and 2.0833% vests each month thereafter, provided that the Reporting Person continues to be employed by the Issuer.
Granted under the Issuer's 2015 Equity Incentive Plan.
Each restricted stock unit represents the contingent right to receive one share of SciClone Pharmaceuticals, Inc.'s common stock.
Each RSU will vest and be settled on August 15, 2017, subject to the reporting person's continued employment, but will terminate upon the occurrence of a change in control on or before March 31, 2017.
Vesting for such RSUs will occur 25% on March 16, 2016, 25% on March 16, 2017, 25% on March 16, 2018, and 25% on March 16, 2019, or on such later date thereafter as the Company's trading window opens, if it is not open on any of such dates, contingent upon the executive's continued employment.
/s/ Friedhelm Blobel, Attorney-in-Fact For Lan Xie
2016-08-16